Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06864208 · ClinicalTrials.gov registry record · NA

Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial

A NA study of Body Weight and Physiological Stress, sponsored by The Miriam Hospital.

Recruiting
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT06864208: Recruiting NA study of Body Weight and Physiological Stress, sponsored by The Miriam Hospital.

NCT06864208 is a NA study of Body Weight and Physiological Stress that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 64 participants, below the 282-participant average among 23 other Body Weight trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06864208, a NA study of Body Weight and Physiological Stress, is actively recruiting participants, sponsored by The Miriam Hospital.

RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

Weight stigma and weight bias internalization (WBI) are common among adolescents at higher weight statuses. WBI is associated with negative physical and mental health outcomes. The current study aims to test an intervention for weight stigma and WBI combined with an evidence-based adolescent weight management program. Eligible adolescents (13-17) will be assigned by chance to one of two groups: 1) a 4-week intervention focused on weight stigma and WBI followed by a 16-week behavioral weight management program; or 2) a 4-week health information control (to include non-weight-related health promotion topics such as smoking and skin cancer prevention) followed by the same 16-week weight management program but without the WBI and weight stigma content. Study outcomes will be assessed at the 4-week and post-treatment (20 week) timepoints.

Primary Outcome

The validated Modified Weight Bias Internalization Scale (WBIS-M) assesses the degree to which people apply negative weight-based stereotypes to themselves and judge themselves negatively due to their weight. Total scores range from 1 to 77, with higher scores indicating a greater degree of WBI.

Interventions

  • BEHAVIORAL Behavioral Weight Management
  • BEHAVIORAL Weight Bias Internalization

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2025-03-25
Est. Completion 2027-02
Phase NA
The Miriam Hospital

136 total trials

What NCT06864208 shows while recruiting

NCT06864208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 282-participant average among 23 other Body Weight trials with a reported enrollment target (77% lower).

The record links to 8 conditions, with Body Weight appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Weight Management is the first listed.

NCT06864208 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06864208 about?

NCT06864208 is a clinical study titled "Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial". Weight stigma and weight bias internalization (WBI) are common among adolescents at higher weight statuses. WBI is associated with negative physical and mental health outcomes. The current study aims to test an intervention for weight stigma and WBI combined with an evidence-based adolescent weight ...

What is the current status of trial NCT06864208?

This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-03-25. Estimated completion is 2027-02.

What conditions does trial NCT06864208 study?

This clinical trial studies the following conditions: Body Weight, Physiological Stress, Weight, Eating Behaviors, Weight Bias.

What interventions are being tested in trial NCT06864208?

The interventions under investigation include: Behavioral Weight Management (BEHAVIORAL), Weight Bias Internalization (BEHAVIORAL).

Who is sponsoring clinical trial NCT06864208?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06864208 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Weight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06864208's enrollment target sits among peer trials

64 13th of 23 higher than 10 of 23 other Body Weight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Body Weight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06864208, the US trial registry maintained by the National Library of Medicine. NCT06864208 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.